Your browser doesn't support javascript.
loading
Immunogenicity and safety of Fluzone(®) intradermal and high-dose influenza vaccines in older adults ≥65 years of age: a randomized, controlled, phase II trial.
Tsang, Peter; Gorse, Geoffrey J; Strout, Cynthia B; Sperling, Malcolm; Greenberg, David P; Ozol-Godfrey, Ayca; DiazGranados, Carlos; Landolfi, Victoria.
Afiliación
  • Tsang P; Sanofi Pasteur, Discovery Drive, Swiftwater, PA 18372, USA. Electronic address: peter.tsang@SanofiPasteur.com.
  • Gorse GJ; Division of Infectious Diseases, Allergy and Immunology, Saint Louis University, Edward A. Doisy Research Center, 8th Floor, 1100 S. Grand Blvd., St. Louis, MO 63104, USA.
  • Strout CB; Coastal Carolina Research Center, 1156 Bowman Rd., Mount Pleasant, SC 29464, USA.
  • Sperling M; Edinger Medical Group, 9900 Talbert Ave., Fountain Valley, CA 92708, USA.
  • Greenberg DP; Sanofi Pasteur, Discovery Drive, Swiftwater, PA 18372, USA.
  • Ozol-Godfrey A; Sanofi Pasteur, Discovery Drive, Swiftwater, PA 18372, USA.
  • DiazGranados C; Sanofi Pasteur, Discovery Drive, Swiftwater, PA 18372, USA.
  • Landolfi V; Sanofi Pasteur, Discovery Drive, Swiftwater, PA 18372, USA.
Vaccine ; 32(21): 2507-17, 2014 May 01.
Article en En | MEDLINE | ID: mdl-24120672

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Vacunas contra la Influenza / Gripe Humana Tipo de estudio: Clinical_trials Límite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Vaccine Año: 2014 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Vacunas contra la Influenza / Gripe Humana Tipo de estudio: Clinical_trials Límite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Vaccine Año: 2014 Tipo del documento: Article